fda glp-1 compounding enforcement november 2025 Drug Recalls and Warnings: Illegal Sales and Misleading Marketing by Novo Nordisk and Eli Lilly FDA Warning Letter Breakdown: Sterility

quality, dosing, and safety cannot be guaranteed

You may have come across the term glucagon-like peptide 1 (GLP-1) or GLP-1 agonist medications in your research

The BMSC-derived exosomal lncRNA Mir9-3hg suppresses cardiomyocyte ferroptosis in ischemia-reperfusion mice via the Pum2/PRDX6 axis

drug prices with those in other developed nations, following an executive order issued in May 2025 for agencies to secure lower costs for consumers

Late-stage trials have now confirmed that retatrutide can drive dramatic weight loss, so much so that experts are talking about the drug as a potential competitor to bariatric surgery

Thats not a forecast its a best-case scenario being presented as a baseline